# Systems biology-driven identification of biomarkers and significant pathways in radiation-induced hormone-sensitive cancers

**Authors:** Suvitha Anbarasu, Sathyanarayan Balaji, Sudha Ramaiah, Anand Anbarasu

PMC · DOI: 10.1007/s12672-025-03892-3 · Discover Oncology · 2025-11-04

## TL;DR

This study identifies biomarkers and pathways linked to hormone-sensitive cancers caused by radiation exposure.

## Contribution

The study proposes novel radiation-sensitive biomarkers specific to hormone-sensitive cancers using systems biology approaches.

## Key findings

- Hub genes like TNF, STAT3, and CTNNB1 were identified as hypoxic signatures in hormone-sensitive cancers.
- MYC and STAT3 in breast cancer, CTNNB1 in prostate cancer, and BRCA1 in ovarian cancer showed significant dysregulation.
- Mutational profiling validated MYC with 18% and STAT3 with 2.6% mutation frequencies.

## Abstract

Radiation-induced damage to nucleic acid and other important cellular constituents could likely cause cancer. The present study has analyzed mutated genes with dysregulated expression signatures due to radiation. We have predicted biomarkers specific to hormone-sensitive cancers (HSCs) namely breast cancer (BC), prostate cancer (PC), ovarian cancer (OC), and endometrial cancer (EC). The study has also attempted to prospect the pathways associated with HSCs and radiation exposure through network analysis and functional enrichment analysis. An overlap of important cell cycle pathways, DNA binding, and transcription activity pathways were found in comparison with HSCs and the radiation hallmark pathways. Hub genes TNF, STAT3, CTNNB1, and MYC in BC; IL1B, CTNNB1, ESR1, and SRC in PC; CTNNB1, BRCA1, JUN, and KRAS in OC; PIK3CA, PTEN, and ESR1 in EC were found as hypoxic signatures due to radiation. Further, the expression survival analysis found MYC and STAT3 in BC, CTNNB1 in PC, JUN, and BRCA1 in OC, and ESR1 in EC were significantly dysregulated and further mutational profiling validated MYC with 18%, STAT3 with 2.6%, and all other genes with 4% mutation. Thus, these genes are proposed as radiation-sensitive diagnostic biomarkers in HSCs.

The online version contains supplementary material available at 10.1007/s12672-025-03892-3.

## Linked entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774], CTNNB1 (catenin beta 1) [NCBI Gene 1499], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609], IL1B (interleukin 1 beta) [NCBI Gene 3553], ESR1 (estrogen receptor 1) [NCBI Gene 2099], SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714], BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672], JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725], KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], PTEN (phosphatase and tensin homolog) [NCBI Gene 5728]
- **Diseases:** breast cancer (MONDO:0004989), prostate cancer (MONDO:0005159), ovarian cancer (MONDO:0005140), endometrial cancer (MONDO:0002447)

## Full-text entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}
- **Diseases:** EC (MESH:D016889), OC (MESH:D010051), PC (MESH:D011471), BC (MESH:D001943), -sensitive cancers (MESH:D009369), hypoxic (MESH:D002534)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12586841/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12586841/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12586841/full.md

---
Source: https://tomesphere.com/paper/PMC12586841